Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus

• Published in: Korean circulation journal Vol. 42; no. 2; pp. 100 - 106
• Main Authors: Choi, Kyu-Young, Kim, Dong-Bin, Kim, Myung-Jun, Kwon, Bum-June, Chang, Seo-Yoon, Jang, Sung-Won, Cho, Eun-Joo, Rho, Tai-Ho, Kim, Jae-Hyung
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society of Cardiology 01.02.2012; 대한심장학회
• Subjects: Original; 내과학; Thrombospondin-1; Coronary artery disease; Diabetes mellitus
• ISSN: 1738-5520; 1738-5555; 1738-5555
• DOI: 10.4070/kcj.2012.42.2.100

Thrombospondin-1 (TSP-1) is associated with atherosclerosis in animals with diabetes mellitus (DM). But, no study has investigated the role of TSP-1 in human atherosclerosis. This study investigated the relationship among plasma TSP-1 concentration, DM, and coronary artery disease (CAD). The study involved 374 consecutive subjects with suspected CAD, who had undergone coronary angiography to evaluate effort angina. Patients were divided into four groups as follows: DM(-) and CAD(-), DM(-) and CAD(+), DM(+) and CAD(-), and DM (+) and CAD(+). We found that plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) (n=103) than those in other patients (n=271) (p<0.01). A multivariate analysis showed that male gender {odds ratio (OR), 2.728; 95% confidence interval (CI), 1.035-7.187}, high density lipoprotein-cholesterol (OR, 0.925; 95% CI, 0.874-0.980), glycated hemoglobin (OR, 1.373; 95% CI, 1.037-1.817), and plasma TSP-1 (OR, 1.004; 95% CI, 1.000-1.008) levels were independently associated with the presence of CAD in patients with DM. Plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) than those in other patients, and plasma TSP-1 levels were independently associated with the presence of CAD in patients with DM. These findings show a possible link between human plasma TSP-1 concentration and CAD in patients with DM.